Levofloxacin Dosing for Pediatric Tuberculosis
For children with tuberculosis, use levofloxacin 15-20 mg/kg once daily for drug-susceptible TB, or 15-20 mg/kg once daily for drug-resistant TB, with no renal adjustment needed unless creatinine clearance is significantly reduced.
Weight-Based Dosing by Clinical Context
Drug-Susceptible TB (Second-Line Agent)
According to the 2016 ATS/CDC/IDSA guidelines, the optimal pediatric dose for levofloxacin in drug-susceptible TB is 15-20 mg/kg once daily 1. Clinical data support this range, though the guidelines acknowledge that optimal dosing is not fully established 1.
Drug-Resistant TB (Core Regimen Component)
For multidrug-resistant TB, the 2019 ATS/CDC/ERS/IDSA guidelines recommend 15-20 mg/kg once daily 2. Recent pharmacokinetic research demonstrates that children require substantially higher mg/kg doses than adults to achieve equivalent drug exposures—ranging from 18 mg/kg/day for younger children to 40 mg/kg/day for older children may be necessary to match adult exposures at 750 mg daily 3, 4.
Age-Specific Considerations
Children clear levofloxacin approximately twice as fast as adults, particularly those under 5 years of age 5. This age-dependent elimination is driven by:
- Maturation of clearance: Reaches 50% of adult capacity at ~2 months of age and 100% by 2 years 3
- Faster elimination in younger children: Results in lower plasma exposures for equivalent mg/kg dosing 6
Practical Dosing by Age Group
- 6 months to <5 years: 15-20 mg/kg once daily (may require higher end of range)
- ≥5 years: 15-20 mg/kg once daily
- Adolescents ≥12 years and >30 kg: Can use adult dosing (750-1000 mg daily) 2
Formulation and Administration
Available formulations 1:
- 250 mg, 500 mg, 750 mg tablets
- 500 mg vials for IV injection
Key administration points:
- Tablets can be crushed for younger children unable to swallow whole tablets 3
- Nasogastric administration is acceptable 3
- Absorption is not affected by age, gender, or timing of meals 6, 7
Renal Function Adjustments
No dose adjustment is needed for normal renal function 2. However:
- Creatinine clearance <50 mL/min: Reduce frequency to 3 times weekly 1, 2
- Levofloxacin is not removed by hemodialysis or peritoneal dialysis—no supplemental doses needed 6
- Children with HIV infection show 16% reduced clearance but typically do not require dose adjustment 3
Monitoring and Safety
Target Concentrations
- Peak concentration (Cmax): 8-12 μg/mL for Mycobacterium tuberculosis 7
- Doses of 15-20 mg/kg achieve Cmax ≥8 μg/mL in children ≥2 years 7
Common Pitfalls to Avoid
- Underdosing: Standard adult mg/kg dosing produces subtherapeutic exposures in children due to faster clearance 3, 5
- Formulation manipulation: Crushing tablets may affect bioavailability—monitor clinical response 3
- Musculoskeletal monitoring: Children have higher incidence of arthralgia (17% moderate, 76% mild) compared to non-fluoroquinolone treatment, though most resolve within 2 months without sequelae 6
Safety Monitoring Requirements
- Baseline and monthly ECGs to assess QTc interval (avoid if QTc >500 ms) 8
- Monthly musculoskeletal assessment for arthralgia, arthritis, tendinopathy, gait abnormality 6
- Most adverse events are mild and self-limited 6
Special Populations
HIV-infected children: Use standard dosing; 16% reduction in clearance is not clinically significant 3
Obese children: Dose based on ideal body weight or modified ideal body weight; consider therapeutic drug monitoring 1
Hepatic impairment: No dose adjustment needed (minimal hepatic metabolism) 6